KLARITOS

Klaritos is a precision medicine company and a subsidiary of Biological Dynamics, focused on the development and commercialization of liquid biopsy solutions for early cancer detection. The company utilizes a proprietary AC Electrokinetics (ACE) technology platform to isolate and analyze biomarkers, such as extracellular vesicles (EVs) and cell-free DNA, directly from blood samples with high sensitivity. Klaritos operates a CLIA-certified laboratory in San Diego and collaborates with pharmaceutical partners to develop companion diagnostics and monitor treatment response. Their primary focus is on high-mortality cancers, including pancreatic, lung, and colorectal cancers, where early detection is critical for improving patient outcomes. By leveraging the unique capabilities of the ACE platform, Klaritos aims to provide clinicians and patients with actionable insights through minimally invasive testing.